| 留园首页 新闻速递首页 热评新闻榜 新闻评论公告 72小时神评妙论 即刻热度新闻 |
https://www.congress.gov/118/meeting/house/115426/documents/HHRG-118-VC00-20230308-SD007.pdf
上面的链接是美国国会网站上的原文，说的就是 Jeffrey Sachs 在国会听证会上的陈述。看完全文就知道他表达的是啥 —— 新冠病毒 老美和中共都有份
上面的链接是美国国会网站上的原文，说的就是 Jeffrey Sachs 在国会听证会上的陈述。看完全文就知道他表达的是啥 —— 新冠病毒 老美和中共都有份
↓↓↓ 共 1 条评论 ↓↓↓
下面是陈述报告里的， 美国无法洗清责任了。
6）On December 12, 2019, the UNC, NIH, and Moderna signed a “Material Transfer Agreement” (MTA) to share materials with regard to “mRNA coronavirus vaccine candidates.” Was this timing a coincidence, or did Moderna, NIH, and UNC already know about the circulation of a new SARS-like virus as of mid-December 2019?
7) On January 13, 2020, NIH and Moderna announced a partnership to develop the mRNA1273 vaccine against SARS-CoV-2, less than 2 days after the first posting of the genome of SARS-CoV-2, and weeks before any known cases of Covid-19 in the United States. When did NIH and Moderna first know about SARS-CoV-2, and how did they reach an agreement to go into Phase I trials of a specific mRNA vaccine within two days of the posting of the genome of the new virus?
6）On December 12, 2019, the UNC, NIH, and Moderna signed a “Material Transfer Agreement” (MTA) to share materials with regard to “mRNA coronavirus vaccine candidates.” Was this timing a coincidence, or did Moderna, NIH, and UNC already know about the circulation of a new SARS-like virus as of mid-December 2019?
7) On January 13, 2020, NIH and Moderna announced a partnership to develop the mRNA1273 vaccine against SARS-CoV-2, less than 2 days after the first posting of the genome of SARS-CoV-2, and weeks before any known cases of Covid-19 in the United States. When did NIH and Moderna first know about SARS-CoV-2, and how did they reach an agreement to go into Phase I trials of a specific mRNA vaccine within two days of the posting of the genome of the new virus?
|
|
|
|
|
|
Copyright (C) 6park.com All rights Reserved.